Back to top
more

Fidelity Advisor Biotechnology Fund: Class I: (MF: FBTIX)

(NASDAQ Mutual Funds) As of Jun 30, 2022 08:00 PM ET

 Add to portfolio

$23.37 USD

-0.27 (-1.14%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

2-Buy of 5   2      

View All Zacks Mutual Fund Rank #1's

Latest Performance as of May 31, 2022

Total Return %* Percentile Rank Objective
YTD -25.17 90
3 months -14.48 90
6 months -23.41 90
1 Year -22.28 87
3 Year 5.31 85
5 Year 6.37 83
10 Year 12.23 72

* Annual for three years and beyond.

Zacks Premium Research for FBTIX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 12.83
% Yield 1.02
% SEC Yield NA
Net Assets (Mil $) 5/31/2022 662.18
%Turnover 5/31/2022 51.00

Risk

3 Year 5 Year 10 Year
Beta 0.86 0.93 1.08
Alpha -6.68 -4.35 -1.04
R Squared 0.47 0.48 0.37
Std. Dev. 22.75 22.07 24.01
Sharpe 0.32 0.35 3.00

Sector / Country Weightings

As of 5/31/2022 % of Portfolio
Health 67.99
Other 23.32
Services 8.09
Finance 0.60

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2022)
% of Portfolio Value (Mil$)
ABBVIE INC 16.93 330.89
TOTAL*MONEY MARKET 10.83 211.68
VERTEX PHARMACEUTICALS IN 10.03 196.07
REGENERON PHARMACEUTICALS 8.41 164.50
ALNYLAM PHARMACEUTICALS I 5.31 103.78
ARGENX SE 3.33 65.05
CYTOKINETICS INC 3.22 62.99
ASCENDIS PHARMA AS 3.15 61.57
SEAGEN INC 2.20 43.05

Stock Holding % of Net Assets

As Of 1/31/2022
Total Issues 101
Avg. P/E NA
Avg. P/Book 4.63
Avg. EPS Growth NA
Avg. Market Value (Mil $) 62,973

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 23.16
Small Value 0.00
Foreign Stock 34.38
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00